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Species Diversity in GLUT 
Expression and Function
Of all cells in the human body, erythro-
cytes express the highest level of the 
GLUT1 glucose transporter, with more 
than 200,000 molecules per cell (Mueck-
ler et al., 1985). We found that GLUT1 
expression is significantly upregulated 
in late-stage erythroblasts, whereas 
glucose transport is decreased (Mon-
tel-Hagen et al., 2008a). This increase in 
GLUT1 expression was associated with 
enhanced transport of L-dehydroascor-
bic acid (DHA), an oxidized intermedi-
ate of ascorbic acid (AA). Moreover, the 
efficient capture of DHA by erythrocyte 
GLUT1 and its immediate reduction to 
AA constitutes a recycling system that 
has evolved in those mammals incapa-
ble of synthesizing vitamin C. This sys-
tem differs markedly from that observed 
in the adult erythrocytes of other spe-
cies, which do not express GLUT1 and 
do not transport DHA. Thus, GLUT1 
expression by erythrocytes is specifi-
cally associated with increased DHA 
transport, whereas erythrocyte glucose 
uptake can be achieved using other 
GLUT transporters.
Glucose Transport in Human Blood 
Cell Progenitors
Carruthers and Naftalin question whether 
our measurements of glucose uptake 
(2-deoxyglucose, 2DG) in human eryth-
roid progenitors reflected decreased 
hexokinase activity rather than changes 
in actual transport. They base their argu-
ment on reference publications stating 
that hexokinase activity is high in eryth-
roblasts and is downregulated during erythroid differentiation (Magnani et al., 
1984; Shinohara et al., 1985). However, 
this argument is spurious as we demon-
strated that glucose transport is already 
decreased in human immature eryth-
roblasts (Montel-Hagen et al., 2008a), 
where the hexokinase activity is very 
high (Magnani et al., 1984).
To further corroborate these data, we 
performed glucose uptake studies at 
early time points during erythroid differ-
entiation induced by recombinant eryth-
ropoietin (rEPO), when most cells are 
proerythroblasts or basophilic erythro-
blasts (for example, see Giarratana et al., 
2005; Figure 1A in Montel-Hagen et al., 
2008a). These immature erythroblasts 
have high hexokinase activity (Magnani 
et al., 1984; Shinohara et al., 1985), but 
we still performed transport assays on 
ice in order to minimize variations in 
enzymatic activity. As demonstrated in 
kinetic analyses, glucose transport in 
early erythroblasts (day 3 of differentia-
tion) was significantly decreased com-
pared to that in CD34+ hematopoietic 
progenitor cells, at time points as early 
as 1 s (see day 0 versus day 3 in Figure 
S1A of this Response, available online). 
We also addressed the relative contribu-
tions of glucose transport and hexoki-
nase activity by assessing the uptake of 
3-O-methylglucose (3-OMG) at an early 
time point of erythropoiesis (day 2 of 
differentiation). These uptake data (see 
Figure S1B here), using a nonmetaboliz-
able sugar analog, remain concordant 
with our previous experiments, thereby 
addressing the concern raised by Car-Cell ruthers and Naftalin. We can indeed 
assert that diminished glucose uptake 
during erythroid differentiation of CD34+ 
progenitor cells results from decreased 
glucose transport.
GLUT1-Mediated DHA Transport
We also demonstrated that GLUT1-
mediated DHA uptake in human red 
blood cells is not inhibited by glucose. 
Carruthers and Naftalin state that these 
results are inconsistent with previous 
findings, but they miss the key point 
that erythrocytes differ from other cell 
types. In nonerythroid cells, glucose 
indeed inhibits GLUT1-mediated DHA 
uptake, as shown by several groups (for 
example, see Rumsey et al., 1997; Mon-
tel-Hagen et al., 2008a). The sole publi-
cation that Carruthers and Naftalin cite 
to support their claim that glucose com-
petitively inhibits DHA uptake in eryth-
roid cells dates from 1975 and is quoted 
out of context. This elegant study, per-
formed years before GLUT1 was identi-
fied, used supraphysiological glucose 
concentrations to compete away DHA 
(Mann and Newton, 1975). This study 
has since been refuted by key publica-
tions demonstrating efficient and rapid 
DHA uptake by erythrocytes, even in 
the presence of a 50-fold molar excess 
of glucose (for example see Mendiratta 
et al., 1998). Our results (Montel-Hagen 
et al., 2008a and Figure S2 here) are in 
complete agreement with these latter 
studies. Thus, Carruthers and Naftalin 
seem to have overlooked published liter-
ature documenting differences between 
erythrocytes and nucleated cells. More-
over, a recent publication has shown that 
glucose does not affect DHA uptake in 
infant dog erythrocytes expressing high 
levels of GLUT1 (Ogawa, 2009). Thus, in 
erythrocytes, physiological glucose con-
centrations do not competitively inhibit 
GLUT1-mediated transport of DHA.137, April 17, 2009 ©2009 Elsevier Inc. 201
We would like to point out that under 
physiological conditions, the major sub-
strate for GLUT1, even in mature human 
erythrocytes, is most likely to be glu-
cose because plasma glucose concen-
trations are ~5 mM, whereas the plasma 
level of DHA is less than 2 µM (reviewed 
in May, 1998). Because it is present at a 
3-log lower molarity than glucose, DHA 
transport into human erythrocytes by 
GLUT1 must be noncompetitive with 
glucose.
Stomatin and GLUT1 Function
Carruthers and Naftalin also question 
our finding of the role of stomatin in 
modulating GLUT1 activity in human 
erythrocytes. Notably, it was earlier 
studies that identified stomatin as a 
GLUT1-binding partner and showed 
that association of GLUT1 with stoma-
tin decreases GLUT1-mediated glucose 
uptake (Zhang et al., 2001). We corrob-
orated these results and demonstrated 
that DHA uptake increases under these 
conditions. Carruthers and Naftalin also 
question our transport experiments 
performed over 10 min in erythrocytes 
from patients with overhydrated heredi-
tary stomatocytosis, who have low or 
no stomatin. However, Carruthers and 
Naftalin have overlooked our experi-
ments on A431 cells harboring ectopic 
stomatin in which we obtained the same 
results at a time point where uptake was 
indeed in the linear range (30 s, Figure 
S6 of Montel-Hagen et al., 2008a), con-
firming the effects of stomatin on modu-
lating GLUT1 function.
Erythropoiesis in Humans and Mice
We studied glucose transporters in 
erythrocytes of other species. Our 
experiments clearly showed that in 
those mammals capable of synthesiz-202 Cell 137, April 17, 2009 ©2009 Elsevier Ining vitamin C, erythrocyte expression 
of GLUT1 is rapidly lost during the 
neonatal period (Montel-Hagen et al., 
2008a, 2008b). We further determined 
that in mice, the erythrocyte transporter 
expressed throughout life is GLUT4, 
even under conditions of anemia-
induced erythropoiesis (Montel-Hagen 
et al., 2008a, 2008b). Thus, glucose 
transport in erythrocytes can be medi-
ated by GLUT4, but the persistence of 
erythrocyte GLUT1 is characteristic of 
vitamin C-deficient species. In these 
latter species, erythrocyte GLUT1 pro-
motes DHA uptake in the most abun-
dant cell in the peripheral circulation, 
compensating, at least in part, for the 
inability to synthesize vitamin C.
Prior to our study, the widespread but 
incorrect assumption was that glucose 
transport in erythrocytes of all mammals 
was mediated by GLUT1 (for example, 
see Leitch and Carruthers, 2007; Naf-
talin and Rist, 1994). One consequence 
of our work on the evolution of erythro-
cyte GLUT1 is our identification of a car-
dinal difference in glucose transporter 
expression between human and rodent 
erythrocytes, opening up new avenues 
of investigation into the differential roles 
of the GLUT1 and GLUT4 transporters in 
red cell physiology (Ogawa, 2009).
Supplemental Data
Supplemental Data include two figures and can 
be found with this article online at http://www.cell.
com/supplemental/S0092-8674(09)00396-1.
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